Sign in

Digital Jagran

Information, Information and Information

  1. Home
  2. /
  3. Biotech
  4. /
  5. Apogee Secures Historic $1.3 Billion Blackstone Deal to Challenge the Eczema Market
Back to News
Biotech

Apogee Secures Historic $1.3 Billion Blackstone Deal to Challenge the Eczema Market

Apogee Therapeutics secures a historic $1.3 billion financing deal with Blackstone Life Sciences. Discover how this non-dilutive capital will propel the eczema drug zumilokibart into Phase 3 trials and challenge market leaders like Dupixent.

S
Surya Pratap Singh
5/28/2026, 9:31:13 AM
Apogee Secures Historic $1.3 Billion Blackstone Deal to Challenge the Eczema Market
Share
0 min read

Digital Jagran

Your trusted source for the latest news, in-depth analysis, and perspectives from India and around the world — in both Hindi and English.

Sections

  • Politics
  • World
  • Business
  • Technology
  • Sports
  • Entertainment

Company

  • About Us
  • Contact Us
  • Privacy Policy
  • Terms of Service
  • Disclaimer

Subscribe

Stay updated with the latest news delivered to your inbox.

© 2026 Digital Jagran. All rights reserved.

PrivacyTermsDisclaimerContact
Home